• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATM 和 ROCK 的双重抑制通过激活 FOXM1 和 E2F1 协同改善复制性衰老中的细胞增殖。

Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1.

机构信息

Department of New Biology, DGIST, Daegu, 42988, Republic of Korea.

Department of Computer Science and Engineering, Kangwon National University, Chuncheon, 24341, Republic of Korea.

出版信息

Commun Biol. 2022 Jul 14;5(1):702. doi: 10.1038/s42003-022-03658-5.

DOI:10.1038/s42003-022-03658-5
PMID:35835838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9283421/
Abstract

The multifaceted nature of senescent cell cycle arrest necessitates the targeting of multiple factors arresting or promoting the cell cycle. We report that co-inhibition of ATM and ROCK by KU-60019 and Y-27632, respectively, synergistically increases the proliferation of human diploid fibroblasts undergoing replicative senescence through activation of the transcription factors E2F1 and FOXM1. Time-course transcriptome analysis identified FOXM1 and E2F1 as crucial factors promoting proliferation. Co-inhibition of the kinases ATM and ROCK first promotes the G2/M transition via FOXM1 activation, leading to accumulation of cells undergoing the G1/S transition via E2F1 activation. The combination of both inhibitors increased this effect more significantly than either inhibitor alone, suggesting synergism. Our results demonstrate a FOXM1- and E2F1-mediated molecular pathway enhancing cell cycle progression in cells with proliferative potential under replicative senescence conditions, and treatment with the inhibitors can be tested for senomorphic effect in vivo.

摘要

衰老细胞周期停滞的多效性需要针对多个因素进行靶向治疗,这些因素可以阻止或促进细胞周期。我们报告称,KU-60019 和 Y-27632 分别抑制 ATM 和 ROCK,通过激活转录因子 E2F1 和 FOXM1,协同增加经历复制性衰老的人二倍体成纤维细胞的增殖。时间进程转录组分析确定 FOXM1 和 E2F1 是促进增殖的关键因素。ATM 和 ROCK 激酶的共同抑制首先通过 FOXM1 的激活促进 G2/M 期过渡,导致通过 E2F1 激活积累经历 G1/S 期过渡的细胞。两种抑制剂的组合比单独使用任何一种抑制剂更显著地增加了这种效果,表明存在协同作用。我们的结果表明,在具有增殖潜力的细胞中,FOXM1 和 E2F1 介导的分子途径增强了复制性衰老条件下的细胞周期进程,并且可以在体内测试抑制剂的衰老样效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/e168f3984d4d/42003_2022_3658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/adb04b613827/42003_2022_3658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/73a284b0d90d/42003_2022_3658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/d3d0b496e13c/42003_2022_3658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/6269e59b6413/42003_2022_3658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/197ea632d948/42003_2022_3658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/e168f3984d4d/42003_2022_3658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/adb04b613827/42003_2022_3658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/73a284b0d90d/42003_2022_3658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/d3d0b496e13c/42003_2022_3658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/6269e59b6413/42003_2022_3658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/197ea632d948/42003_2022_3658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baa/9283421/e168f3984d4d/42003_2022_3658_Fig6_HTML.jpg

相似文献

1
Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1.ATM 和 ROCK 的双重抑制通过激活 FOXM1 和 E2F1 协同改善复制性衰老中的细胞增殖。
Commun Biol. 2022 Jul 14;5(1):702. doi: 10.1038/s42003-022-03658-5.
2
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.ATM 和 p53 通过 E2F 调节乳腺癌表柔比星治疗和耐药中的 FOXM1 表达。
Mol Cancer Ther. 2011 Jun;10(6):1046-58. doi: 10.1158/1535-7163.MCT-11-0024. Epub 2011 Apr 25.
3
Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.肿瘤抑制因子 BIN1 的缺失可使核蛋白 E2F1 激活 ATM 的丝氨酸/苏氨酸激酶,并使癌细胞对顺铂产生耐药性。
J Biol Chem. 2019 Apr 5;294(14):5700-5719. doi: 10.1074/jbc.RA118.005699. Epub 2019 Feb 7.
4
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.CDCA5 通过促进 E2F1 和 FOXM1 的结合加速乳腺癌的进展。
J Transl Med. 2024 Jul 8;22(1):639. doi: 10.1186/s12967-024-05443-w.
5
Linkage of E2F1 transcriptional network and cell proliferation with respiratory chain activity in breast cancer cells.乳腺癌细胞中E2F1转录网络及细胞增殖与呼吸链活性的关联
Cancer Sci. 2016 Jul;107(7):963-71. doi: 10.1111/cas.12953. Epub 2016 May 20.
6
The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.表柔比星治疗后,p38丝裂原活化蛋白激酶-MK2轴调节E2F1和FOXM1的表达。
Mol Cancer Res. 2012 Sep;10(9):1189-202. doi: 10.1158/1541-7786.MCR-11-0559. Epub 2012 Jul 16.
7
Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.FoxM1 的下调通过抑制 MRN-ATM 介导的 DNA 修复使鼻咽癌细胞对顺铂敏感。
BMB Rep. 2019 Mar;52(3):208-213. doi: 10.5483/BMBRep.2019.52.3.249.
8
The human ion channel TRPM2 modulates cell survival in neuroblastoma through E2F1 and FOXM1.人类离子通道TRPM2通过E2F1和FOXM1调节神经母细胞瘤中的细胞存活。
Sci Rep. 2022 Apr 15;12(1):6311. doi: 10.1038/s41598-022-10385-8.
9
CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.CDC2 是肺动脉高压中血管平滑肌细胞增殖的重要驱动因素,通过 FOXM1 和 PLK1 实现。
Int J Mol Sci. 2021 Jun 28;22(13):6943. doi: 10.3390/ijms22136943.
10
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.叉头框蛋白M1(FOXM1)靶向NBS1以调控DNA损伤诱导的衰老和表柔比星耐药性。
Oncogene. 2014 Aug 7;33(32):4144-55. doi: 10.1038/onc.2013.457. Epub 2013 Oct 21.

引用本文的文献

1
Developing a novel aging assessment model to uncover heterogeneity in organ aging and screening of aging-related drugs.开发一种新型衰老评估模型,以揭示器官衰老的异质性并筛选与衰老相关的药物。
Genome Med. 2025 Jul 24;17(1):83. doi: 10.1186/s13073-025-01501-0.
2
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence.人类成纤维细胞衰老的系统转录组分析及时间建模
Front Aging. 2024 Aug 29;5:1448543. doi: 10.3389/fragi.2024.1448543. eCollection 2024.
3
FOXM1: a new therapeutic target of extramammary Paget disease.

本文引用的文献

1
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan.在体内对FOXM1转录因子进行周期性诱导可延缓自然衰老和早衰表型,并延长健康寿命。
Nat Aging. 2022 May;2(5):397-411. doi: 10.1038/s43587-022-00209-9. Epub 2022 May 5.
2
Cellular senescence in ageing: from mechanisms to therapeutic opportunities.细胞衰老与衰老:从机制到治疗机会。
Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95. doi: 10.1038/s41580-020-00314-w. Epub 2020 Dec 16.
3
ATM mediated-p53 signaling pathway forms a novel axis for senescence control.
叉头框蛋白M1:一种乳腺外佩吉特病的新治疗靶点。
Sci Rep. 2024 Feb 19;14(1):4048. doi: 10.1038/s41598-024-54773-8.
4
FOXM1: A small fox that makes more tracks for cancer progression and metastasis.FOXM1:一个制造更多癌症进展和转移轨迹的小狐狸。
Semin Cancer Biol. 2023 Jul;92:1-15. doi: 10.1016/j.semcancer.2023.03.007. Epub 2023 Mar 22.
ATM 介导的 p53 信号通路为衰老控制形成了一个新的轴。
Mitochondrion. 2020 Nov;55:54-63. doi: 10.1016/j.mito.2020.09.002. Epub 2020 Sep 17.
4
Global transcriptional downregulation of TREX and nuclear trafficking machinery as pan-senescence phenomena: evidence from human cells and tissues.全球转录下调 TREX 和核转运机制作为普遍衰老现象:来自人类细胞和组织的证据。
Exp Mol Med. 2020 Aug;52(8):1351-1359. doi: 10.1038/s12276-020-00490-x. Epub 2020 Aug 28.
5
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review.CDC25C在细胞周期调控及临床癌症治疗中的作用:一项系统综述
Cancer Cell Int. 2020 Jun 3;20:213. doi: 10.1186/s12935-020-01304-w. eCollection 2020.
6
FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation.FOXM1 核转录因子转位到线粒体并抑制氧化磷酸化。
Mol Biol Cell. 2020 Jun 15;31(13):1411-1424. doi: 10.1091/mbc.E19-07-0413. Epub 2020 Apr 29.
7
A comprehensive review of the roles of E2F1 in colon cancer.E2F1在结肠癌中作用的全面综述。
Am J Cancer Res. 2020 Mar 1;10(3):757-768. eCollection 2020.
8
Y-27632 preserves epidermal integrity in a human skin organ-culture (hSOC) system by regulating AKT and ERK signaling pathways.Y-27632 通过调节 AKT 和 ERK 信号通路来维持人皮肤器官培养(hSOC)系统中的表皮完整性。
J Dermatol Sci. 2019 Nov;96(2):99-109. doi: 10.1016/j.jdermsci.2019.10.006. Epub 2019 Nov 3.
9
E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration.E2F1 通过调控靶基因 FGF13 并改变细胞迁移来驱动乳腺癌转移。
Sci Rep. 2019 Jul 24;9(1):10718. doi: 10.1038/s41598-019-47218-0.
10
E2F1 mediates the downregulation of POLD1 in replicative senescence.E2F1 介导复制性衰老中 POLD1 的下调。
Cell Mol Life Sci. 2019 Jul;76(14):2833-2850. doi: 10.1007/s00018-019-03070-z. Epub 2019 Mar 20.